400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR2100042375
结束
/
/
/
2021-01-21
/
/
新型冠状病毒肺炎(COVID-19)
Evaluation of Biomarkers for Prediction of Morbidity and Mortality in COVID-19 at a Tertiary Care Center in Pakistan
Evaluation of Biomarkers for Prediction of Morbidity and Mortality in COVID-19 at a Tertiary Care Center in Pakistan
74800
To evaluate the association of Serum Procalcitonin and other biochemical markers including ferritin, CRP, IL-6 with severity in Coronavirus disease 2019 (COVID-19), hospitalized patients and to test the hypothesis that they are an independent predictor of mortality.
析因分组(即根据危险因素或暴露因素分组)
探索性研究/预试验
Owing to the retrospective data analysis, biochemical marker levels were obtained within 48 hours of admission for all in patients as routine care protocol of COVID-19.
N/A
No
/
71;86
/
2020-03-01
2020-08-10
/
both genders and aged 18 years and older groups with SARS-CoV-2 positive on a reverse-transcriptase polymerase chain reaction (PCR) test and received treatment at our center;
请登录查看1) biochemical work up on admission not undertaken; 2) known thalassemic cases.;
请登录查看No
74800
BioArt2026-01-16
药明康德2026-01-16
GLP1减重宝典2026-01-15
温江高新区2026-01-15
良医汇肿瘤资讯2026-01-15
氨基观察2026-01-15
Juventas合源生物2026-01-15
医药速览2026-01-15
CPHI制药在线2026-01-15
CPHI制药在线2026-01-15